Enbiosis “The World’s First Digital Twin & AI Powered Nutraceutical Formulation Engine”
  • Science
  • Platform
  • Partnership
  • About Us
  • FAQs
  • Blogs
Menu
  • Science
  • Platform
  • Partnership
  • About Us
  • FAQs
  • Blogs
  • HOME
  • SCIENCE
  • PLATFORM
  • PARTNERSHIP
  • ABOUT US
  • FAQs
  • Blogs
  • CONTACT US
Contact Us

Награды

Enbiosis Award Sanofi
Программа предпринимательства PharmUp Победитель в номинации “Страна”

Награды

Enbiosis Award Bayer
Программа акселерации Bayer G4A

Награды

Enbiosis Award Global Challenge
Победитель Глобального Инновационного Соревнования

Награды

Enbiosis scientific frontier winner
Победитель научных фронтов

Награды

Enbiosis Award Nutra Ingredients award
Финалист NutraIngredients Europe & Asia Awards

Награды

UK Teck rocketship award to Enbiosis
Победитель премии Tech Rocketship от правительства Великобритании

Награды

Frame 3
Победитель Lab Awards в номинации «Лучшая автоматизация и инновации в области данных»

Награды

Upgrade Your Product Line with AI-Powered Blends
Partner with Enbiosis to access clinically-backed, ready-to-manufacture formulations tailored to your specific health categories.
Become a Partner
Explore the Science
Powered by Enbiosis®
25 Cabot Square, London E14 4QZ
Science

Our Story

Digital Twin AI

Clinical Studies

Publications

Platform

Product Catalogue

Product Formats

Longevity

Category Availability

Partnership

Licensing Model

Become a Partner

Global Regions

Contact Us

About Us
Contact Us
© 2026 Enbiosis. All rights reserved. Powered by Enbiosis®
© 2026 Enbiosis. All rights reserved.
Powered by Enbiosis®
  • About
  • Science
  • Our Solutions
  • Collaborate With Us
    • Partnership
    • Practitioner
    • Affiliate
  • My Account
    • Login
    • Register
      • Register as partner
      • Register as practitioner
      • Register as affiliate
      • Register as patient
  • Order now
  • Login
Cookies are placed on our site. For detailed information about cookies, you can review the Terms of Use and Privacy Policy.
Accept